Investors seek damages in securities class action against The Chemours Company
Investors have until December 7 to file for lead plaintiff status in a lawsuit alleging Chemours misrepresented market demand for refrigerants.
Kahn Swick & Foti, LLC has initiated a securities class action lawsuit against The Chemours Company. The complaint alleges that the company overstated aftermarket demand for its refrigerants, leading to a decline in shareholder value.
According to the legal filing, the company’s disclosures misled the market, contributing to an 18% drop in the firm's stock price. The litigation aims to recover losses for shareholders who purchased stock during the period affected by the alleged misstatements.
Investors who incurred substantial losses are eligible to file lead plaintiff applications until December 7, 2026. The firm is currently coordinating with affected shareholders as the litigation proceeds.